Suppr超能文献

酶的底物选择性小分子调节剂:机制与机遇。

Substrate-selective small-molecule modulators of enzymes: Mechanisms and opportunities.

机构信息

Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.

出版信息

Curr Opin Chem Biol. 2023 Feb;72:102231. doi: 10.1016/j.cbpa.2022.102231. Epub 2022 Nov 28.

Abstract

Small-molecule inhibitors of enzymes are widely used tools in reverse chemical genetics to probe biology and explore therapeutic opportunities. They are often compared with genetic knockdown or knockout and are expected to produce phenotypes similar to the genetic perturbations. This review aims to highlight that small molecule inhibitors of enzymes and genetic perturbations may not necessarily produce the same phenotype due to the possibility of substrate-selective or substrate-dependent effects of the inhibitors. Examples of substrate-selective inhibitors and the mechanisms for the substrate-selective effects are discussed. Substrate-selective modulators of enzymes have distinct advantages and cannot be easily replaced with biologics. Thus, they present an exciting opportunity for chemical biologists and medicinal chemists.

摘要

酶的小分子抑制剂在反向化学遗传学中被广泛用作研究生物学和探索治疗机会的工具。它们通常与基因敲低或敲除进行比较,并期望产生与遗传扰动相似的表型。本综述旨在强调,由于抑制剂可能具有底物选择性或底物依赖性作用,因此酶的小分子抑制剂和遗传扰动不一定会产生相同的表型。讨论了底物选择性抑制剂的例子和底物选择性作用的机制。酶的底物选择性调节剂具有明显的优势,并且不能轻易地被生物制剂所替代。因此,它们为化学生物学家和药物化学家提供了一个令人兴奋的机会。

相似文献

2
Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.Sirtuin 6 的合成小分子激活的结构基础。
Angew Chem Int Ed Engl. 2017 Jan 19;56(4):1007-1011. doi: 10.1002/anie.201610082. Epub 2016 Dec 19.
5
Potent and Selective Inhibitors of Human Sirtuin 5.强效且选择性的人源 Sirtuin 5 抑制剂。
J Med Chem. 2018 Mar 22;61(6):2460-2471. doi: 10.1021/acs.jmedchem.7b01648. Epub 2018 Mar 12.
6
Emerging Therapeutic Potential of SIRT6 Modulators.SIRT6 调节剂的新兴治疗潜力。
J Med Chem. 2021 Jul 22;64(14):9732-9758. doi: 10.1021/acs.jmedchem.1c00601. Epub 2021 Jul 2.
7
Sirtuins: multifaceted drug targets.Sirtuins:多效的药物靶点。
Curr Mol Med. 2011 Dec;11(9):709-18. doi: 10.2174/156652411798062412.

引用本文的文献

本文引用的文献

1
PROTAC targeted protein degraders: the past is prologue.PROTAC 靶向蛋白降解剂:过去是序幕。
Nat Rev Drug Discov. 2022 Mar;21(3):181-200. doi: 10.1038/s41573-021-00371-6. Epub 2022 Jan 18.
2
Dissecting the biology of mTORC1 beyond rapamycin.解析雷帕霉素之外的 mTORC1 生物学。
Sci Signal. 2021 Sep 21;14(701):eabe0161. doi: 10.1126/scisignal.abe0161.
4
Understanding the Function of Mammalian Sirtuins and Protein Lysine Acylation.理解哺乳动物 Sirtuins 与蛋白赖氨酸酰化作用的功能。
Annu Rev Biochem. 2021 Jun 20;90:245-285. doi: 10.1146/annurev-biochem-082520-125411. Epub 2021 Apr 13.
6
Binding site for activator MDL-801 on SIRT6.激活剂MDL-801在SIRT6上的结合位点。
Nat Chem Biol. 2021 May;17(5):519-521. doi: 10.1038/s41589-021-00749-y. Epub 2021 Mar 1.
8
Nitro-fatty acids as activators of hSIRT6 deacetylase activity.硝酰化脂肪酸作为 hSIRT6 去乙酰化酶活性的激活剂。
J Biol Chem. 2020 Dec 25;295(52):18355-18366. doi: 10.1074/jbc.RA120.014883. Epub 2020 Oct 29.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验